fCAL® turbo Packaging Update
The packaging for the BÜHLMANN fCAL® turbo calibrator and control kits is changing from the current opaque white bottles to…
Read more
Serum Calprotectin Analysis: ELISA vs. Turbidimetric Assays
In the Autumn of 2023, technical specialists from BÜHLMANN visited Great Ormond Street Children’s Hospital (GOSH) to collaboratively establish a…
Experience the Next Level CALEX® Workflow Revolution
In 2014, the CALEX Cap transformed faecal calprotectin extraction workflows in laboratories. Now, with CALEX faecal calprotectin collection kits, patients…
The Workflow Revolution Continues for Serum Calprotectin
Following on from the success of the fCAL® turbo and the fPELA® assays, BÜHLMANN has now launched the sCAL® turbo…
New Presentation Format for UK NEQAS
BÜHLMANN has been the market leading provider of faecal calprotectin assays in the UK for over 10 years, holding a…
Faecal Calprotectin Indicates Intestinal Inflammation in COVID-19
In this pilot study, a relation between GI symptoms, intestinal inflammation (determined by FC) and faecal SARS-CoV-2-RNA in hospitalised patients…
Calprotectin is Now Part of the New ECCO & ESGAR Guidelines
Faecal calprotectin (FC) is now part of the new official European Crohn’s and Colitis Organisation (ECCO) and the European Society…
The New Faecal Calprotectin Care Pathway | NICE
The New Faecal Calprotectin Care Pathway, developed by Dr James Turvill, Consultant Gastroenterologist at York Teaching Hospitals NHS Foundation Trust,…
Three Simple Tests Could Save the NHS at least £6.9 Billion
A report from BIVDA and Innovate UK has identified that wider use of some IVD tests could save money and…
NICE releases Medtech Innovation Briefing on calprotectin point of care and home testing for monitoring IBD treatment.
On 4th December 2017 the National Institute for Health and Care Excellence issued a Medtech Innovation Briefing [MIB132]: ‘Point-of-care and home faecal…